CAS: 17874-79-2; 5-(Methoxycarbonyl)Picolinic Acid

该化合物是一种多功能的丙烯基酯衍生物,其价值为两功能组,可促成多种化学变异. 其甲氧基碳基和碳boxylate moyies使其成为制药合成,农用化学发展和协调化学的有用中间体. 该化合物具有高度的回动性和选择性,有助于在复杂的有机合成物中高效衍生.

英文名称5-(Methoxycarbonyl)Picolinic Acid
中文名称5-(甲氧羰基)-2-吡啶羧酸
IUPAC名称5-(methoxycarbonyl)picolinic acid
其它别名5-(甲氧羰基)吡啶-2-羧酸; 5-(Methoxycarbonyl)Pyridine-2-Carboxylic Acid
CAS编号17874-79-2
MFCD编号:MFCD00179343
EINECS号:672-842-2
分子式:C8H7NO4
分子量:181.15
产品CID: 919180
产品分类有机原料→分子砌块→芳杂环类化合物→吡啶类化合物

相似结构搜索
InChIKey: NTCKZTBRFXTYBD-UHFFFAOYSA-N
InChI=1S/C8H7NO4/c1-13-8(12)5-2-3-6(7(10)11)9-4-5/h2-4H,1H3,(H,10,11)…
计算化学: 氢键受体数4.0氢键供体数1.0可旋转键数2.0

相似化合物

6221-01-8 40749-33-5 53574-58-6

物理性质

熔点187°C
沸点347.9°C at 760 mmHg
闪点164.2±23.7 °C
密度1.4±0.1 g/cm3
pKa:3.21±0.10(预测)
PSA:76.49
LogP:0.5664
折射率1.560
蒸汽压0.0±0.8 mmHg at 25°C
溶解性Chloroform (Sparingly, Heated), DMSO (Slightly), Methanol (Slightly)
外观形态白色至类白色固体
储存条件在惰性气体(氮气或氩气)下 2-8°C

MSDS等安全信息

GHS象形图
GHS符号GHS07;
注释: Exclamation mark
危险类别特定目标器官毒性 - 单次接触类别3
皮肤腐蚀/刺激类别2
严重眼刺激类别2
急性毒性类别4(经口)
严重眼刺激类别2A
警示词Warning(警告)
危险描述H335 |可能引起呼吸道刺激.
H315 |造成皮肤刺激.
H319 |造成严重眼刺激.
H302 |吞咽有害.
防范说明P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
危险等级IRRITANT
危险品标志Xi,Xn
安全声明26-36/37/39-22
危险类别码36/37/38-22

欧盟法规

C&L通报

上下游产品

合成工艺路线路线简述

2,5-二吡啶羧酸置于甲醇,Sodium Hydroxide,硫酸体系中,化学反应 21.0H,反应生成5-(甲氧羰基)-2-吡啶羧酸
参考文献:Conjugates Of Artemisinin-Related Endoperoxides And Hydrazone Derivatives For The Treatment Of Cancer
标题:Conjugates Of Artemisinin-Related Endoperoxides And Hydrazone Derivatives For The Treatment Of Cancer
摘要:具有与联接剂通过连接剂共价耦合的肟基的青蒿素相关内过氧化物基团的化合物.使用这些化合物治疗癌症的组合物和方法.

海关参考信息

2912110000-甲醛
2915110000-甲酸
2933310010-吡啶
2909199090-其他醚及其衍生物
💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
详情请参考：📖 海关编码查询和海关进出口税则

专利信息

专利号:US-8012972-B2
优先权日:2007-03-28
标题:Pyridinecarboxylic acid (2-aminophenyl) amide derivative having urea structure
发明人：MOGI HIROYUKI; TAJIMA HISASHI; MISHINA NORIKO; YAMAZAKI YUSUKE; YONEDA SHINJI; WATANABE KATSUHIKO; FUJIKAWA JUNKO; YAMAMOTO MINORU
权利人:SANTEN PHARMACEUTICAL CO LTD
摘要:Objects of the present invention are to study the synthesis of a novel pyridinecarboxylic acid (2-aminophenyl)amide derivative having a novel urea structure and to find a pharmacological effect of the derivative. The invention provides a compound represented by the formula (1) or a salt thereof. In the formula, R 1 and R 2 represent a hydrogen atom, a lower alkyl group or the like; R 3 represents a hydroxy group, a lower alkoxy group, a lower cycloalkyloxy group, an aryloxy group, a carboxy group, a lower alkoxycarbonyl group, â€”OCONR a R b , â€”NR c R d or the like; R 4 and R 5 represent a halogen atom, a lower alkyl group, a hydroxy group, a lower alkoxy group or the like; R a and R b represent a hydrogen atom, a lower alkyl group, a lower cycloalkyl group, an aryl group, a heterocyclic group or the like; R c and R d represent a hydrogen atom, a lower alkyl group, a lower cycloalkyl group, an aryl group or the like; X represents a lower alkylene group; Y represents a single bond, a lower alkylene group; W 1 -W 2 represents Nâ€”C or Câ€”N; and l and m represent 0, 1, 2 or 3.

专利号:US-2010152208-A1
优先权日:2007-05-23
标题:Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
发明人：LEGER SERGE; DESCHENES DENIS; FORTIN REJEAN; ISABEL ELISE; POWELL DAVID
权利人:MERCK FROSST CANADA LTD
摘要:Bicyclic heteroaromatic compounds of structural formula I are inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD). The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease, such as atherosclerosis; obesity; Type 2 diabetes; insulin resistance; hyperglycemia; Metabolic Syndrome; neurological disease; cancer; and liver steatosis. Formula (I).